Article
[Immunotherapy for BRAF mutant metastatic melanoma.]
Recenti progressi in medicina - 1 Dec 2020
Rossi Ernesto
Abstract excerpt
The treatment of cutaneous melanoma harboring BRAF mutation has been greatly enriched. BRAF/MEK inhibitors can improve the outcome of patients with this disease. On the other hand, immunotherapy can also be effective. A focus on the role of immune checkpoint inhibitors in advanced melanoma with BRAF mutation has been performed.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
